Brought to you by:
Structured exercise after acute DVT may reduce long-term complications
New research presented at VAM 2026 showed how structured aerobic exercise combined with standard anticoagulation in patients with acute lower extremity deep vein thrombosis (DVT) may help significantly reduce the risk of developing post-thrombotic syndrome (PTS). The study was funded by the…
Stent maintenance: Sustaining long-term patency in deep venous system
This advertorial is sponsored by Stryker/Inari Medical. As venous stenting becomes more common, the focus must now shift to what occurs after the procedure, according to consultant vascular surgeon Stephen Black, MD, FRCS. The concept of stent maintenance is key,…
When to re-intervene: Stent surveillance and the effective use of RevCore mechanical thrombectomy to clear in-stent thrombosis
This advertorial is sponsored by Stryker/Inari Medical. How a finely tuned stent surveillance program plays a crucial role in raising the alarm of worsening symptoms in DVT patients and identifies those who might require reintervention with mechanical thrombectomy. For Jake…
Wound healing in space: Vascular surgeons produce wide-ranging review
How a group of vascular surgeons is working to plug gaps in knowledge and inspire colleagues to recognize the specialty’s essential role in future space travel. It’s not so much a case of where-no-vascular-surgeon-has-gone-before as making sure aspects of the…
Novel thrombectomy system for VTE used successfully in first tranche of first-in-human cases
SonoVascular has announced the successful completion of an initial set of eight deep vein thrombosis (DVT) cases using its SonoThrombectomy system as part of a first-in-human (FIH) study of the device. All cases achieved a complete Marder score reduction as…
How the RevCore and VenaCore thrombectomy catheters combine to broaden treatment approach among advanced deep vein thrombosis patients previously limited to few options
This advertorial is sponsored by Inari Medical. For Joseph M. Liechty, MD, a vascular surgeon with Texas Vascular Associates in Plano, Texas, the emergence of the RevCoreTM and VenaCoreTM devices (Inari Medical) have helped broaden his treatment strategies for advanced…
Endologix announces 36-month results of DETOUR2 study
Endologix has announced the final 36-month results from the DETOUR2 study—a prospective, single-arm, international, multicentre clinical evaluation of the novel Detour system for fully percutaneous femoropopliteal bypass procedures. A press release details that the findings highlight the durable efficacy of…
Novel AI-assisted DVT diagnostic pathway aims to ‘democratize’ point-of-care ultrasound
A new deep vein thrombosis (DVT) diagnostic pathway incorporating non-expert artificial intelligence (AI)-guided compression ultrasound could reduce workload and costs for healthcare systems while providing a quicker diagnosis and improving patient care. Efthymios (Makis) Avgerinos, MD, of Athens, Greece, shared…
First-in-human study of SonoThrombectomy system completed
SonoVascular has announced the successful initiation of its first-in-human study (FIH) of the company’s SonoThrombectomy system, an ultrasound-facilitated, thrombolytic-enhanced platform that utilizes multiple mechanisms of action to treat patients with venous thromboembolism (VTE). The catheter-based system combines microbubble-mediated cavitation with…
Inari Medical updates ClotTriever XL IFU amid FDA recall notice
The Food and Drug Administration (FDA) has issued a Class I recall—the most serious type—for Inari Medical‘s ClotTriever XL, 30mm device due to reports of patient injury, and death from device entrapment and pulmonary emboli (PE). The device remains on…